Aurobindo Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Aurobindo Pharma	Alkem Laboratories	Glenmark Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	879.0 .	188.0 .	13.0 .
Number of ANDA's Approved By USFDA	750.0 .	167.0 .	25.0 .
US DMF Filings	315.0 .	n/a	n/a
Europe DMF Filings	2127.0 .	n/a	n/a
R&D as a % of Total Sales	4.7 %	3.7 %	7.3 %
Financials
5 yr Average ROE	12.72 %	17.38 %	3.99 %
5yr average Equity Multiplier	1.46	1.39	1.78
5yr Average Asset Turnover Ratio	0.68	0.86	0.8
5yr Avg Net Profit Margin	12.5 %	14.54 %	2.85 %
Price to Book	2.02	5.05	6.3
P/E	20.35	28.43	56.64
5yr Avg Cash Conversion Cycle	-46.37 Days	-61.46 Days	-150.94 Days
Inventory Days	59.62 Days	56.11 Days	32.28 Days
Days Receivable	30.33 Days	44.62 Days	32.34 Days
Days Payable	121.28 Days	122.42 Days	201.14 Days
5yr Average Interest Coverage Ratio	43.54	24.48	4.25
5yr Avg ROCE	15.27 %	22.76 %	17.54 %
5yr Avg Operating Profit Margin	19.22 %	18.44 %	15.96 %
5 yr average Debt to Equity	0.19	0.18	0.38
5yr CAGR Net Profit	-8.16 %	6.44 %	1.54 %
5yr Average Return on Assets	8.64 %	12.47 %	2.09 %
Shareholdings
Promoter Holding	51.82 %	51.2 %	46.65 %
Share Pledged by Promoters	17.5 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.01 %	-5.96 %	0.0
Change in Mutual Fund Holding (3 Yrs)	12.02 %	6.0 %	12.22 %

	Aurobindo Pharma	Alkem Laboratories	Glenmark Pharma
Product Wise Break-Up	Product Wise Break-Up Formulations 88.36 Active Pharmaceutical Ingredient (API) 11.64 Pharmaceutical 0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Formulations 0 Glenmark generics 0 Glenmark Pharma (Branded generics) 0 Pharmaceutical 100.0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Formulations 0 Formulations 39.54 Branded Generics 60.46 Pharmaceutical 0
Location Wise Break-Up	Location Wise Break-Up USA 44.3 Europe 29.7 Rest of the World 17.0 India 9.0 Latin America 0 North America 0	Location Wise Break-Up Europe 0 Rest of the World 0 North America 0 India 69.13 Latin America 0 USA 29.72 Others 1.15	Location Wise Break-Up Europe 12.36 Rest of the World 10.91 North America 73.99 India 2.73 Latin America 0 USA 0 Others 0.01
Asset Break-Up	Asset Break-Up India 65.14 USA 18.21 Europe 7.85 Rest of the World 0 Latin America 0 North America 0 Others 8.8	Asset Break-Up Europe 0 Rest of the World 0 North America 0 India 70.19 Latin America 0 USA 28.27 Others 1.54	Asset Break-Up Europe 3.09 Rest of the World 4.94 North America 42.56 India 49.4 Latin America 0 USA 0 Others 0.01